PMN
ProMIS Neurosciences Inc.
9.40$
-13.5%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 69.9% | 93.3% | 92.7% | 97.1% | 98.1% | 97.7% | 89.6% | 99.8% | 99.7% | 100.0% | 100.0% | 100.0% | |
| 8.5% | 78.5% | 73.6% | 77.8% | 80.6% | 80.1% | 74.3% | 95.5% | 84.9% | 92.5% | 70.3% | 66.6% | |
| 8.5% | 82.1% | 77.8% | 63.4% | 82.0% | 82.2% | 79.8% | 95.7% | 85.5% | 92.7% | 70.5% | 67.0% | |
| 0.2% | 0.8% | 0.7% | 0.1% | 0.0% | 0.1% | 0.1% | 0.2% | 0.6% | 0.6% | 0.4% | 0.4% | |
| – | -4.6% | -3.6% | -1.7% | -1.4% | -2.7% | -2.2% | -0.2% | -0.6% | – | – | – | |
| – | – | – | – | 0.1% | – | 7.2% | 0.0% | 0.0% | – | – | – | |
| -2.8% | -1.8% | -1.8% | -0.6% | -0.5% | -0.5% | -0.6% | – | – | – | – | – | |
| 27.7% | 6.5% | 7.1% | 2.8% | 1.9% | 2.3% | 3.0% | 0.2% | 0.3% | – | – | – | |
| 167.3% | 47.9% | 92.8% | 29.4% | 61.0% | 80.8% | 173.4% | 68.1% | 119.5% | 72.4% | 12.8% | 113.7% | |
| 167.3% | 47.9% | 92.8% | 29.4% | 61.0% | 80.8% | 173.4% | 5.2% | 92.6% | 68.7% | 11.7% | 113.4% | |
| – | 10.3% | 12.5% | – | – | – | – | – | – | – | – | – | |
| 167.3% | 36.1% | 66.4% | 12.0% | 24.0% | 22.4% | 40.3% | 2.3% | 43.0% | 57.6% | 9.2% | 27.7% | |
| – | – | – | – | – | – | – | 17.3% | – | – | – | – | |
| -67.3% | 52.1% | 7.2% | 70.6% | 39.0% | 19.2% | -73.4% | 31.9% | -19.5% | 27.6% | 87.2% | -13.7% | |
| -12,367.1% | -3,349.8% | -4,339.9% | -2,212.2% | -1,961.9% | -3,162.8% | -5,144.7% | -350.4% | -1,159.0% | -686.3% | -479.5% | -1,420.2% | |
| 13.7% | 6.3% | 11.7% | 6.3% | 5.4% | 8.4% | 13.7% | 1.0% | 2.4% | 3.6% | 5.6% | 19.1% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.